Press

notices

A paper by our representative, Inogawa, was published in Volume 42, Issue 3 of Neurotherapeutics, the journal of the Japanese Society of Neurotherapeutics.


A paper written by our CEO, Takateru Inokawa, has been published in Volume 42, Issue 3 of the journal “Neurotherapy,” published by the Japan Society of Neurotherapy. Title : Digital Transformation (DX) and Enrollment Support in Clinical Research and Trials – The Forefront of

Japan’s Clinical Trial DX, Platforms, AI, and DCT Utilization
Author: Takateru Inokawa , Buzzreach Inc.

Please see the full version below:
https://www.jsnt.gr.jp/system/journal.php?magazine_code=cq3neuro,cq3shini